ASX - By Stock
|
RHY |
Re:
Ann: Investor Presentation - December 2020
|
|
clio
|
61 |
26K |
11 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
61
|
26K
|
11
|
|
ASX - By Stock
|
M7T |
Re:
M7T Metrics
|
|
clio
|
33 |
15K |
6 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
33
|
15K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Investor Presentation
|
|
clio
|
42 |
18K |
4 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
42
|
18K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Appoints Global Manufacturer for ColoSTAT
|
|
clio
|
29 |
11K |
10 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
29
|
11K
|
10
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Appoints Global Manufacturer for ColoSTAT
|
|
clio
|
29 |
11K |
1 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
29
|
11K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 AGM 2020 Presentation
|
|
clio
|
16 |
5.8K |
2 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
16
|
5.8K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 AGM 2020 Presentation
|
|
clio
|
16 |
5.8K |
4 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
16
|
5.8K
|
4
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 AGM 2020 Presentation
|
|
clio
|
16 |
5.8K |
7 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
16
|
5.8K
|
7
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 AGM 2020 Presentation
|
|
clio
|
16 |
5.8K |
6 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
16
|
5.8K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Investor Presentation
|
|
clio
|
42 |
18K |
5 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
42
|
18K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Investor Presentation
|
|
clio
|
42 |
18K |
10 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
42
|
18K
|
10
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Investor Presentation
|
|
clio
|
42 |
18K |
4 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
42
|
18K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Ethics Approval Received, New Clinical Trial Site Added
|
|
clio
|
13 |
6.7K |
1 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
13
|
6.7K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Ethics Approval Received, New Clinical Trial Site Added
|
|
clio
|
13 |
6.7K |
2 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
13
|
6.7K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 Signs 7-year Contract with Trinity Health
|
|
clio
|
76 |
26K |
4 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
76
|
26K
|
4
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Appendix 4C - quarterly
|
|
clio
|
41 |
17K |
1 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
41
|
17K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Q1 Business Update
|
|
clio
|
10 |
3.6K |
0 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
10
|
3.6K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Q1 Business Update
|
|
clio
|
10 |
3.6K |
0 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
10
|
3.6K
|
0
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Appendix 4C - quarterly
|
|
clio
|
41 |
17K |
1 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
41
|
17K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Appendix 4C - quarterly
|
|
clio
|
41 |
17K |
0 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
41
|
17K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
clio
|
13 |
4.5K |
2 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
13
|
4.5K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Annual Report to Shareholders FY20
|
|
clio
|
63 |
21K |
1 |
19/10/20 |
19/10/20 |
ASX - By Stock
|
63
|
21K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Annual Report to Shareholders FY20
|
|
clio
|
63 |
21K |
1 |
19/10/20 |
19/10/20 |
ASX - By Stock
|
63
|
21K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Annual Report to Shareholders FY20
|
|
clio
|
63 |
21K |
3 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
63
|
21K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
The GOOD and the BAD
|
|
clio
|
26 |
23K |
0 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
26
|
23K
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical Goldman Sachs Healthcare Forum Presentation
|
|
clio
|
31 |
25K |
1 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
31
|
25K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Files Registration Statement for Proposed US IPO
|
|
clio
|
10 |
4.9K |
0 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
10
|
4.9K
|
0
|
|
ASX - By Stock
|
MSB Algorithmic Trading |
Re:
For investors waking up THERE IS NO NEWS YET
|
|
clio
|
79 |
55K |
5 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
79
|
55K
|
5
|
|
Charts
|
M7T |
Re:
Close to breakout
|
|
clio
|
428 |
233K |
2 |
28/09/20 |
28/09/20 |
Charts
|
428
|
233K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Change of Director's Interest Notice x 3
|
|
clio
|
13 |
5.5K |
9 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
13
|
5.5K
|
9
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 Announces FY2020 Financial Results
|
|
clio
|
35 |
12K |
3 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
35
|
12K
|
3
|
|
ASX - By Stock
|
WMI |
Re:
Ann: Oversubscribed Share Purchase Plan and Placement
|
|
clio
|
57 |
16K |
0 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
57
|
16K
|
0
|
|
ASX - By Stock
|
WMI |
Re:
Ann: Oversubscribed Share Purchase Plan and Placement
|
|
clio
|
57 |
16K |
1 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
57
|
16K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces Plans for Potential US listing and IPO
|
|
clio
|
36 |
16K |
6 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
36
|
16K
|
6
|
|
Charts
|
M7T |
Re:
Close to breakout
|
|
clio
|
428 |
233K |
2 |
27/08/20 |
27/08/20 |
Charts
|
428
|
233K
|
2
|
|
Charts
|
M7T |
Re:
Close to breakout
|
|
clio
|
428 |
233K |
3 |
27/08/20 |
27/08/20 |
Charts
|
428
|
233K
|
3
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 Announces FY2020 Financial Results
|
|
clio
|
35 |
12K |
5 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
35
|
12K
|
5
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Preliminary Final Report and Audited Financial Statements
|
|
clio
|
4 |
1.5K |
7 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
4
|
1.5K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Completes Successful FDA and EMA Meetings for Phase 3
|
|
clio
|
7 |
4.1K |
13 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
7
|
4.1K
|
13
|
|
ASX - By Stock
|
OPT |
Re:
Goldman Sachs Buy recommendation Target price $5.20
|
|
clio
|
4 |
3.4K |
0 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
4
|
3.4K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
$5 party?
|
|
clio
|
108 |
41K |
4 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
108
|
41K
|
4
|
|
ASX - By Stock
|
M7T |
Re:
Newby query
|
|
clio
|
1 |
910 |
4 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
1
|
910
|
4
|
|
ASX - By Stock
|
WMI |
Re:
Ann: Outperformance, increased FF final and special div, and SPP
|
|
clio
|
24 |
8.6K |
3 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
24
|
8.6K
|
3
|
|
ASX - By Stock
|
WMI |
Re:
Ann: Outperformance, increased FF final and special div, and SPP
|
|
clio
|
24 |
8.6K |
3 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
24
|
8.6K
|
3
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
clio
|
2.9K |
1.2M |
0 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
2.9K
|
1.2M
|
0
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
clio
|
2.9K |
1.2M |
0 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
2.9K
|
1.2M
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Is anyone still holding?
|
|
clio
|
16 |
8.3K |
2 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
16
|
8.3K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
explain the market cap
|
|
clio
|
134 |
55K |
0 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
134
|
55K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: S&P DJI Announces June 2020 Quarterly Rebalance
|
|
clio
|
8 |
3.0K |
4 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
8
|
3.0K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME
|
|
clio
|
124 |
52K |
3 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
124
|
52K
|
3
|
|